| 1 | Study | 0.83% | |
| 2 | Health | 0.77% | |
| 3 | New | 0.75% | |
| 4 | Cancer | 0.65% | |
| 5 | COVID-19 | 0.51% | |
| 6 | Medicina | 0.48% | |
| 7 | Disease | 0.43% | |
| 8 | BMC | 0.41% | |
| 9 | Treatment | 0.35% | |
| 10 | Patients | 0.35% | |
| 11 | May | 0.31% | |
| 12 | COVID | 0.31% | |
| 13 | Research | 0.29% | |
| 14 | News | 0.27% | |
| 15 | Risk | 0.27% | |
| 16 | Brain | 0.26% | |
| 17 | Case | 0.24% | |
| 18 | Heart | 0.24% | |
| 19 | Dengue | 0.22% | |
| 20 | Covid | 0.21% | |
| 21 | AI | 0.21% | |
| 22 | Hospital | 0.21% | |
| 23 | HIV | 0.2% | |
| 24 | Horoscopo | 0.2% | |
| 25 | Review | 0.2% | |
| 26 | Abril | 0.2% | |
| 27 | Bird | 0.2% | |
| 28 | Malaria | 0.19% | |
| 29 | Woman | 0.19% | |
| 30 | Salud | 0.18% | |
| 31 | Africa | 0.18% | |
| 32 | Report | 0.18% | |
| 33 | Flu | 0.18% | |
| 34 | Public | 0.18% | |
| 35 | Therapy | 0.18% | |
| 36 | Medical | 0.18% | |
| 37 | UK | 0.17% | |
| 38 | Clinical | 0.17% | |
| 39 | US | 0.16% | |
| 40 | World | 0.16% | |
| 41 | MS | 0.16% | |
| 42 | U.S. | 0.16% | |
| 43 | Rare | 0.16% | |
| 44 | Ozempic | 0.16% | |
| 45 | France | 0.16% | |
| 46 | Care | 0.15% | |
| 47 | Breast | 0.15% | |
| 48 | Infectious | 0.15% | |
| 49 | Syndrome | 0.15% | |
| 50 | Covid-19 | 0.15% | |
|
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
|||
ADN Chile
2024-04-25 04:28:06
Tour de Cure backs further development of Noxopharm's preclinical brain cancer candidate
The National Tribune
2024-04-23 14:38:15
PhD candidates, GLO express frustration at unexpected partial denials of COVID funding extension
The Brown Daily Herald
2024-04-23 10:05:00
Candidatos deben tener como prioridad el bienestar de mexicanos: CEESP
Vanguardia MX
2024-04-23 06:08:00
BSA bureau
2024-04-22 16:34:33
Medicina y Salud Publica
2024-04-21 20:12:52